Narrow search
Showing 1 - 10 of 33,695
Cover Image
The long-term impact of price controls in medicare part D
Moreno, Gigi; Eijndhoven, Emma van; Benner, Jennifer; … - In: Forum for health economics & policy : an evolving … 20 (2017) 2, pp. 1-56
Persistent link: https://www.econbiz.de/10011817398
Cover Image
The effects of drug market regulation on pharmaceutical prices in Europe : overview and evidence from the market of ACE inhibitors
Schulenburg, Fritz von der; Vandoros, Sotiris; Kanavos, … - In: Health economics review 1 (2011) 18, pp. 1-8
in reducing pharmaceuticals prices. Results are not as strong for demand side measures. Profit controls and the use of …
Persistent link: https://www.econbiz.de/10009503923
Cover Image
Regulation of pharmaceutical prices : evidence from a reference price reform in Denmark
Kaiser, Ulrich; Méndez, Susan J.; Rønde, Thomas; … - 2012
Reference price systems for prescription drugs constitute widely adopted cost containment tools. In these systems, patients co-pay a fraction of the difference between a drug's pharmacy retail price and a reference price that is set by the government. Reference prices are either determined...
Persistent link: https://www.econbiz.de/10009751931
Cover Image
Impact of price control on pharmaceutical sector with reference to India
Kolte, Ashutosh; Mal, Hoshiar; Fulambrikar, Mugdha; … - In: International journal of intelligent enterprise 8 (2021) 1, pp. 90-104
Persistent link: https://www.econbiz.de/10012512495
Cover Image
International impact of external reference pricing : should national policy-makers care?
Fontrier, Anna-Maria; Gill, Jennifer; Kanavos, Panos - In: The European journal of health economics : HEPAC ; … 20 (2019) 8, pp. 1147-1164
Persistent link: https://www.econbiz.de/10012221319
Cover Image
Pharmaceutical Policies in OECD Countries : Reconciling Social and Industrial Goals
Jacobzone, S. - 2000
pharmaceuticals in publicly-financed health care systems. This paper describes recent trends in pharmaceutical expenditure and …
Persistent link: https://www.econbiz.de/10012444523
Cover Image
Fair prices for medicines? : exploring competent authorities’ and public payers’ preferences on pharmaceutical policies
Vogler, Sabine - In: Empirica : journal of european economics 46 (2019) 3, pp. 443-469
Persistent link: https://www.econbiz.de/10012242289
Cover Image
The only prescription is transparency : the effect of charge-price-transparency regulation on healthcare prices
Christensen, Hans B.; Floyd, Eric; Maffett, Mark - In: Management science : journal of the Institute for … 66 (2020) 7, pp. 2861-2882
Persistent link: https://www.econbiz.de/10012268550
Cover Image
Late-stage pharmaceutical R&D and pricing policies under two-stage regulation
Jobjörnsson, Sebastian; Forster, Martin; Pertile, Paolo; … - In: Journal of health economics 50 (2016), pp. 298-311
Persistent link: https://www.econbiz.de/10011589153
Cover Image
Pharmaceutical expenditure in Germany : future development, political influence and economic impact
Wolf, Sascha G. - 2009 - 1. Aufl. 2009
Abstract: Der Arzneimittelsektor der Gesetzlichen Krankenversicherung stand wiederholt im Fokus zahlreicher Gesundheitsreformen. Dennoch ist es bislang nicht gelungen, den Trend steigender Ausgaben nachhaltig zu bremsen. Die vorliegende Untersuchung leistet einen Beitrag dazu, die Ursachen...
Persistent link: https://www.econbiz.de/10011674632